No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia

Netherlands Journal of Medicine

Volumn 62, Issue 7, 2004, Pages 246-253

  Spoelstra de Man, A M E ^a   Brouwer, C B ^c   Terheggen, F ^c   Bollen, J M ^a   Stehouwer, C D A ^a,b   Smulders, Y M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; FOLIC ACID; HOMOCYSTEINE; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIUM LESION; ETHNOLOGY; HUMAN; HYPERHOMOCYSTEINEMIA; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INFLAMMATION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 4444240064     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002; 288:2015-23.
2. Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1998;18:133-8.
3. Hoogeveen EK, Kostense PJ, Jakobs C, et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes. Circulation 2000;101:1506-11.
4. Woo KS, Chook P, Lolin YI, et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997;96:2542-4.
5. Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet 1998;351:36-7.
6. Aken BE van, Trip MD, Kastelein JJP, Deventer SJH, Reitsma PH. Inflammatory markers and homocysteine in patients with premature atherosclerosis. thesis, University of Amsterdam 1999.
7. Stehouwer CDA, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002;51:1157-65.
8. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, Ottolander GJH den. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992;340:319-23.
9. Shukla N, Thompson CS, Angelini GD, Mikhailidis DP, Jeremy JY. Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits. Diabetologia 2002;45:1325-31.
10. Homocysteine Lowering Trialists' Collaboration. Lowering homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998;316:894-8.
11. Schnyder G, Roffi M, Pin R, et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001;29:1593-600.
12. Vermeulen EGJ, Stehouwer CDA, Twisk JWR, et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 2000;355:517-22.
13. Woo KS, Check P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 1999;34:2002-6.
14. Dijk RAJM van, Rauwerda JA, Steyn M, Twisk JWR, Stehouwer CDA. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure, but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness. A 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2001;21:2072-9.
15. Aken BE van, Heijer M den, Bos GMJ, Deventer SJH, Blom HJ, Reitsma PH. Cytokine levels in subjects with moderate hyperhomocysteinemia before and after vitamin supplementation. Atherosclerosis: in press.
16. Vermeulen EGJ, Rauwerda JA, Berg M vd, et al. Homocysteine-lowering treatment reduces urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein. Eur J Clin Invest 2003;33:209-15.
17. Smulders YM, Slaats EH, Rakic M, Smulders FTY, Stehouwer CDA, Silberbusch J. Short term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus. J Lab Clin Med 1998;132:39-46.
18. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Chin Biochem 1991;29:549-54.
19. Jager A, Hinsbergh VW van, Kostense PJ, et al. Increased levels of soluble vascular cell adhesion molecule-1 are associated with risk of cardiovascular mortality among non-insulin dependent diabetes mellitus: the Hoorn Study. Diabetes 2000;49:485-91.
20. Mulvihill NT, Foley JB, Murphy RT, Curtin R, Crean PA, Walsh M. Risk stratification in unstable angina and non-Q-wave myocardial infarction using soluble cell adhesion molecules. Heart 2001;85:623-7.
21. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
22. Becker A, Hinsbergh VW van, Kostense PJ, et al. Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects. Eur J Clin Invest 2000;30:763-70.
23. Targher C, Zenari L, Bertolini L, Falezza G, Muggeo M, Zoppini G. Plasma total homocysteine levels are associated with von Willebrand Factor, soluble intercellular adhesion molecule-1, and soluble tumor necrosis factor-alpha receptors in young type 1 diabetic patients without clinical evidence of macrovascular complications. Diabetes Care 2001;24,1496-7.
24. Stehouwer CDA, Lambert J, Donker AJ, Hinsbergh VW van. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34:55-68.
25. Baliga BS, Reynolds T, Fink LM, Fonseca VA. Hyperhomocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine. Endocr Pract 2000;6:435-41.
26. Thambyrajah J, Landray MJ, Jones HJ, McGlynn FJ, Wheeler DC, Townend JN. A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. J Am Coll Cardiol 2001;37:1858-63.
27. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure. Circulation 2000;102:871-5.
28. Pullin CH, Ashfield-Watt PAL, Burr ML, et al. Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylene tetrahydrofolate reductase (C677T) genotype. J Am Coll Cardiol 2001;38:1799-805.
29. Mangoni AA, Arya R, Ford E, et al. Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial. Thromb Res 2003;15:13-7.
30. Mayer OJ, Simon J, Rosolova H, Hromadka M, Subrt I, Vobrubova I. The effects of folate supplementation on some coagulation parameters and oxidative status surrogates. Eur J Clin Pharmacol 2002;58:1-5.
31. Grundt H, Nilsen DW, Mansoor MA, Hetland O, Nordoy A. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion molecules. Pathophysiol Haemost Thromb 2003;33:88-95.
32. Baro L, Fonolla J, Pena JL, et al. n-3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans. Clin Nutr 2003;22L:175-82.
33. Doshi SN, McDowell IFW, Moat SJ, et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002;105:22-6.
34. Willems FF, Aangevaeren WRM, Boers GHJ, Blom HJ, Verheugt FWA. Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease. J Am Coll Cardiol 2002;40:766-72.
35. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000;102:2479-83.
36. Mangoni AA, Sherwood RA, Swift CG, Jackson SH. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med 2002;252:497-503.
37. Hirsch S, Pia De la Maza M, Yanez P, et al. Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation. Clin Cardiol 2002;25:495-501.
38. Sydow K, Schwedhelm E, Arakawa N, et al. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocysteinemia: effects of L-arginine and B vitamins. Cardiovasc Res 2003;57:244-52.
39. Etten RW van, Koning EJP de, Verhaar MC, Gaillard CAJM, Rabelink, TJ. Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 2002;45:1004-10
40. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci 1999;96:235-39.